Cocoon Bioscience Announces Closing Of A €15M Funding Round To Scale High Value Proteins Production
Cocoon Bioscience is an innovative manufacturer of specialty enzymes for the life science and pharma sector and growth factor proteins for the alternative protein industry.
The round led by Columbus Venture Partners and Cleon Capital includes several blue-chip co-investors such as the Spanish listed company Viscofan, international venture capital funds North South Ventures, Gestión de Capital Riesgo del País Vasco, SGEIC, S.A., and Sangha Capital, and other strategic partners.
The company is currently building its new facilities in Zamudio (Bilbao), which will be operational in the first half of 2024.
